The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chronic anthracycline cardiotoxicity

The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chronic anthracycline cardiotoxicity

Bibliographic Details
Main Authors: Kotwinski Paul, Smith Gillian, Sanders Julie, Ma Louise, Cooper Jackie, Thomas Michael, Mythen Michael (Monty) G, Jones Alison, Montgomery Hugh E, Pennell Dudley J
Format: Article
Language:English
Published: BMC 2013-01-01
Series:Journal of Cardiovascular Magnetic Resonance

Similar Items